| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Department of Endocrinology and Metabolism, National Research Institute for Child Health and Development (N.K., N.S., T.T.), Tokyo 154-8567, Japan; Department of Pediatrics, Sendai City Hospital (M.O.), Miyagi 984-8501, Japan; Department of Pediatrics, Watari Hospital (T.Ho.), Fukushima 960-8141, Japan; Department of Pediatrics, Tohoku University School of Medicine (E.O.), Miyagi 980-8574, Japan; and Department of Food and Nutrition, Nakamura Gakuen University (T.Ha.), Fukuoka 814-0198, Japan
Address all correspondence and requests for reprints to: Noriyuki Katsumata, M.D., Department of Endocrinology and Metabolism, National Research Institute for Child Health and Development, 3-35-31 Taishido, Setagaya-ku, Tokyo 154-8567, Japan. E-mail: . nkatsumata{at}nch.go.jp
Abstract
Cholesterol side-chain cleavage enzyme (P450scc) catalyzes the conversion of cholesterol to pregnenolone in mitochondria, which is the first step in the biosynthesis of all steroid hormones. Until now, no homozygous or compound heterozygous mutations in CYP11A have been described in humans. Here we describe novel compound heterozygous mutations in CYP11A in a patient with congenital adrenal insufficiency born to healthy parents. One mutation, a maternally inherited R353W mutation, resulted in markedly reduced P450scc activity by the single amino acid substitution, indicating that Arg353 is a crucial amino acid residue for P450scc activity. The other mutation, a de novo A189V mutation in the paternal allele, did not affect the P450scc activity by the single amino acid substitution and turned out to be a splicing mutation, which created a novel alternative splice-donor site. It resulted in a deletion of 61 nucleotides in the open reading frame and thus partially inactivated CYP11A. These experimental data are consistent with the clinical findings indicating that the patient had partially preserved ability to synthesize adrenal steroid hormones. This is the first report of the compound heterozygote for the CYP11A mutations with congenital adrenal insufficiency and the phenotypically normal heterozygote in humans.
This article has been cited by other articles:
![]() |
P. Rubtsov, M. Karmanov, P. Sverdlova, P. Spirin, and A. Tiulpakov A Novel Homozygous Mutation in CYP11A1 Gene Is Associated with Late-Onset Adrenal Insufficiency and Hypospadias in a 46,XY Patient J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 936 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Shih, N.-C. Hsu, C.-C. Huang, T.-S. Wu, P.-Y. Lai, and B.-c. Chung Mutation of Mouse Cyp11a1 Promoter Caused Tissue-Specific Reduction of Gene Expression and Blunted Stress Response without Affecting Reproduction Mol. Endocrinol., April 1, 2008; 22(4): 915 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Kim, L. Lin, N. Huang, C. A. Quigley, T. W. AvRuskin, J. C. Achermann, and W. L. Miller Severe Combined Adrenal and Gonadal Deficiency Caused by Novel Mutations in the Cholesterol Side Chain Cleavage Enzyme, P450scc J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 696 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Y. Baker, L. Lin, C. J. Kim, J. Raza, C. P. Smith, W. L. Miller, and J. C. Achermann Nonclassic Congenital Lipoid Adrenal Hyperplasia: A New Disorder of the Steroidogenic Acute Regulatory Protein with Very Late Presentation and Normal Male Genitalia J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4781 - 4785. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. al Kandari, N. Katsumata, S. Alexander, and M. A. Rasoul Homozygous Mutation of P450 Side-Chain Cleavage Enzyme Gene (CYP11A1) in 46, XY Patient with Adrenal Insufficiency, Complete Sex Reversal, and Agenesis of Corpus Callosum J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2821 - 2826. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Pikuleva CHOLESTEROL-METABOLIZING CYTOCHROMES P450 Drug Metab. Dispos., April 1, 2006; 34(4): 513 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhangoo, W.-X. Gu, S. Pavlakis, H. Anhalt, L. Heier, S. Ten, and J. L. Jameson Phenotypic Features Associated with Mutations in Steroidogenic Acute Regulatory Protein J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6303 - 6309. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Miller Minireview: Regulation of Steroidogenesis by Electron Transfer Endocrinology, June 1, 2005; 146(6): 2544 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Hiort, P.-M. Holterhus, R. Werner, C. Marschke, U. Hoppe, C.-J. Partsch, F. G. Riepe, J. C. Achermann, and D. Struve Homozygous Disruption of P450 Side-Chain Cleavage (CYP11A1) Is Associated with Prematurity, Complete 46,XY Sex Reversal, and Severe Adrenal Failure J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 538 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Jameson Of Mice and Men: The Tale of Steroidogenic Factor-1 J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5927 - 5929. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |